Skip to content

A consistent comparative clinical study of MET amplification in Chinese lung cancer patients on multiple hospital and central laboratory platforms

A consistent comparative clinical study of MET amplification in Chinese lung cancer patients on multiple hospital and central laboratory platforms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057321
Enrollment
Unknown
Registered
2022-03-08
Start date
2021-07-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary disease

Interventions

Gold Standard:FISH test
Index test:tissue MET amplification tests

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Informed consent or an IRB-approved informed waiver is required prior to any research-specific procedure; 2. Histologically or cytologically confirmed locally advanced or metastatic NSCLC that progressed after prior egFR-TKI therapy of any generation; 3. The patient signs an informed consent form or the EC grants an informed exemption, agreeing to provide fresh samples (tumor tissue and blood samples) or archived specimens or previous test results. Samples should be obtained after prior EGFR-TKI therapy and before the use of MET inhibitors.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
MET amplification results of FISH test of tumor tissue carried out by hospital department;The RESULTS of MET amplification were detected by NGS in central laboratories and hospital departments;

Secondary

MeasureTime frame
Baseline characteristics: demographics, relevant medical history, disease characteristics, and history of cancer treatment;

Countries

China

Contacts

Public ContactZongan Liang

West China Hospital, Sichuan University

liang.zongan@163.com+86 18980601259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026